Lisa Spalding

Lisa Spalding is a Senior Research Fellow at The University of Western Australia, where she works within the UWA Medical School and the UWA Centre for Medical Research (affiliated with the Harry Perkins Institute of Medical Research) in Perth, Australia. With a research focus spanning breast cancer, bladder cancer, and broader oncology fields, she has established herself as an active contributor to cancer research with an h-index of 8 and 211 citations.

Dr. Spalding's research interests center on cancer biology and treatment outcomes, with particular expertise in breast cancer disparities among Indigenous populations, mammographic breast density correlations with treatment outcomes, molecular pathways in hepatocellular carcinoma, and AI-powered diagnostics for bladder cancer. Her work bridges clinical oncology with molecular biology to improve cancer detection, treatment, and patient outcomes, contributing to UN Sustainable Development Goals related to health and well-being.

Her recent publications demonstrate a strong focus on translational cancer research, with particular emphasis on understanding treatment resistance mechanisms, developing predictive biomarkers, and addressing health disparities in cancer care. Dr. Spalding frequently collaborates on international, multi-center studies, indicating her work's significance in the global oncology community.

Dr. Spalding has been involved in significant research projects including the ANZUP Below The Belt Grant 2021 (October 2021-June 2025) as Investigator 04 and the Suzanne Cavanagh Grant focused on dendritic cells in colon cancer recurrence (January 2018-December 2019) as Investigator 07. Her collaborative network includes frequent co-authorship with researchers such as Redfern, A., Meehan, K., and Hayne, D.